Evidence map›Paper›PMID 28676836›Full record

ArticleOxidative medicine and cellular longevity2017

Genetic Nrf2 Overactivation Inhibits the Deleterious Effects Induced by Hepatocyte-Specific c-met Deletion during the Progression of NASH.

Pierluigi Ramadori, Hannah Drescher, Stephanie Erschfeld, Athanassios Fragoulis, Thomas W Kensler, Christoph Jan Wruck, Francisco Javier Cubero, Christian Trautwein, Konrad L Streetz, Daniela C Kroy

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Pierluigi RamadoriDepartment of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.ORCID 0000-0001-6581-9648
Hannah DrescherDepartment of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
Stephanie ErschfeldDepartment of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
Athanassios FragoulisDepartment of Anatomy and Cell Biology, University Hospital RWTH Aachen, Aachen, Germany.
Thomas W KenslerDepartment of Pharmacology & Chemical Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Christoph Jan WruckDepartment of Anatomy and Cell Biology, University Hospital RWTH Aachen, Aachen, Germany.
Francisco Javier CuberoDepartment of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
Christian TrautweinDepartment of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
Konrad L StreetzDepartment of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
Daniela C KroyDepartment of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.ORCID 0000-0001-7728-2112
RWTH Aachen University · DEUniversidad Complutense de Madrid · ESUniversity of Pittsburgh · US

Funding

Targeting Nrf2 for Cancer ChemopreventionR35CA197222 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KENSLER, THOMAS W · 2015 to 2021
$6.7M
NCI NIH HHS R35 CA197222
6 · The paper itself

Abstract

We have recently shown that hepatocyte-specific c-met deficiency accelerates the progression of nonalcoholic steatohepatitis in experimental murine models resulting in augmented production of reactive oxygen species and accelerated development of fibrosis. The aim of this study focuses on the elucidation of the underlying cellular mechanisms driven by Nrf2 overactivation in hepatocytes lacking c-met receptor characterized by a severe unbalance between pro-oxidant and antioxidant functions. Control mice (c-met

Indexed as

AnimalsDisease ProgressionHepatocytesMaleMiceMice, Inbred C57BLMice, KnockoutNF-E2-Related Factor 2Non-alcoholic Fatty Liver DiseaseProto-Oncogene Proteins c-metReactive Oxygen SpeciesNfe2l2 protein, mouseNF-E2-Related Factor 2Proto-Oncogene Proteins c-metReactive Oxygen Species

Identifiers

PMID28676836
PMCPMC5476895
OpenAlexW2623444888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.